152 related articles for article (PubMed ID: 30575894)
1. LncRNA HOXD-AS1 promotes preeclampsia progression via MAPK pathway.
Jiang J; Zhao ZM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8561-8568. PubMed ID: 30575894
[TBL] [Abstract][Full Text] [Related]
2. Lowly expressed EGFR-AS1 promotes the progression of preeclampsia by inhibiting the EGFR-JAK/STAT signaling pathway.
Zhao ZM; Jiang J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6190-6197. PubMed ID: 30338781
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CCAT1 promotes the progression of preeclampsia by regulating CDK4.
Li JL; Li R; Gao Y; Guo WC; Shi PX; Li M
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1216-1223. PubMed ID: 29565477
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
Hu YC; Wang AM; Lu JK; Cen R; Liu LL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PRNCR1 promoted the progression of eclampsia by regulating the MAPK signal pathway.
Jiao S; Wang SY; Huang Y
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3635-3642. PubMed ID: 29949134
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of lncRNA TCL6 promotes preeclampsia progression by regulating PTEN.
Wu JL; Wang YG; Gao GM; Feng L; Guo N; Zhang CX
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4066-4072. PubMed ID: 31173275
[TBL] [Abstract][Full Text] [Related]
8. [Interaction mechanism and influence between fatty acid oxidation in trophoblast cells and p38MAPK signal transduction pathway of severe preeclampsia].
Sun XL; Yang Z; Wang W; Wang XY; Wang JL; Wu SY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):853-7. PubMed ID: 24444564
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
10. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
Liu R; Wang X; Yan Q
Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
[TBL] [Abstract][Full Text] [Related]
11. Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
Szabo S; Mody M; Romero R; Xu Y; Karaszi K; Mihalik N; Xu Z; Bhatti G; Fule T; Hupuczi P; Krenacs T; Rigo J; Tarca AL; Hassan SS; Chaiworapongsa T; Kovalszky I; Papp Z; Than NG
Pathol Oncol Res; 2015 Jul; 21(3):659-68. PubMed ID: 25583406
[TBL] [Abstract][Full Text] [Related]
12. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
15. Small extracellular vesicles-transported lncRNA TDRKH-AS1 derived from AOPPs-treated trophoblasts initiates endothelial cells pyroptosis through PDIA4/DDIT4 axis in preeclampsia.
Chen Q; He J; Liu H; Huang Q; Wang S; Yin A; Chen S; Shen X; Xiao Y; Hu H; Jiang J; Chen W; Wang S; Huang Z; Li J; Peng Y; Wang X; Yang X; Wang Z; Zhong M
J Transl Med; 2023 Jul; 21(1):496. PubMed ID: 37488572
[TBL] [Abstract][Full Text] [Related]
16. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
Dong S; Wang R; Wang H; Ding Q; Zhou X; Wang J; Zhang K; Long Y; Lu S; Hong T; Ren H; Wong K; Sheng X; Wang Y; Zeng Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):110. PubMed ID: 30823895
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA VIM Antisense RNA 1 (VIM-AS1) Plays an Important Role in Development of Preeclampsia by Regulation of Epithelial Mesenchymal Transition.
Zhao X; Jiang X; Liu Z; Zhou M; Zhang J; Wang X; Li X
Med Sci Monit; 2019 Nov; 25():8306-8314. PubMed ID: 31685789
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326/SLC27A4.
Ji W; Wang Q; Yang J
Cancer Cell Int; 2020; 20():161. PubMed ID: 32425696
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding HOTTIP regulates preeclampsia by inhibiting RND3.
Li L; Zhang X; Hong SL; Chen Y; Ren GH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3277-3285. PubMed ID: 29917176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
